Nature, nurture and human disease

Nature

Volumn 421, Issue 6921, 2003, Pages 412-414

  Chakravarti, Aravinda ^a   Little, Peter ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DNA;

HUMAN BIOLOGY;

GENETIC ENGINEERING;

DNA;

BIOLOGY; DNA STRUCTURE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEREDITY; INHERITANCE; MOLECULAR GENETICS; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHORT SURVEY; SMOKING;

DNA; ENVIRONMENT; GENES; GENETIC DISEASES, INBORN; GENETICS, MEDICAL; HUMANS; LIFE STYLE;

EID: 85015054307     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01401     Document Type: Short Survey

References (17)

1. Jaroff, L. The gene hunt. Time 20 March, 62-67 (1989)
2. Arcos-Burgos, M. & Muenke, M. Genetics of population isolates. Clin. Genet. 61, 233-247 (2002).
3. Aidoo, M. et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359, 1311-1312 (2002).
4. Tishkoff, S. A. & Williams, S. M. Genetic analysis of African populations: human evolution and complex disease. Nature Rev. Genet 3, 611-621 (2002).
5. Chakravarti, A. Single nucleotide polymorphisms:...to a future of genetic medicine. Nature 409, 822-823 (2001).
6. Carrasquillo, M. M. et al. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nature Genet. 32, 237-244 (2002).
7. Cox, N. J. Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the calpain-10 gene. Hum. Mol. Genet. 10, 2301-2305 (2001).
8. Sullivan, P. F. et al. Analysis of epistasis in linked regions in the Irish study of high-density schizophrenia families. Am. J. Med. Genet. 105, 266-270 (2001).
9. Boyle, J. P. et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the United States. Diabetes Care 24, 1936-1940 (2001).
10. Münger, K. Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest. 20, 71-81 (2002).
11. Panda, S., Hogenesch, J. B. & Kay, S. A. Circadian rhythms from flies to human. Nature 417, 329-335 (2002).
12. MacGregor, A. J. et al. Twins: novel uses to study complex traits and genetic diseases. Trends Genet. 16, 131-134 (2000).
13. Wertz, D. C. Ethics watch. Nature Rev. Genet. 3, 496 (2002).
14. Evans, W. E. & Johnson, J. A. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu. Rev. Genomics Hum. Genet. 2, 9-39 (2001).
15. Lown, K. S. et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J. Clin. Invest. 99, 2545-2553 (1997).
16. Wright, A. F., Carothers, A. D. & Campbell, H. Gene-environment interactions - the BioBank UK study. Pharmacogenomics J. 2, 75-82 (2002).
17. Stucker, I. et al. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 23, 1475-1481 (2002).